β-Adrenergic Receptor Signaling and Heart Failure : From Bench to Bedside
Copyright © 2019 Elsevier Inc. All rights reserved..
Despite improvements in management and therapeutic approach in the last decades, heart failure is still associated with high mortality rates. The sustained enhancement in the sympathetic nervous system tone, observed in patients with heart failure, causes alteration in β-adrenergic receptor signaling and function. This latter phenomenon is the result of several heart failure-related molecular abnormalities involving adrenergic receptors, G-protein-coupled receptor kinases, and β-arrestins. This article summarizes novel encouraging preclinical strategies to reactivate β-adrenergic receptor signaling in heart failure, including pharmacologic and gene therapy approaches, and attempts to translate acquired notions into the clinical setting.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Heart failure clinics - 15(2019), 3 vom: 01. Juli, Seite 409-419 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bencivenga, Leonardo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
β-Adrenergic receptors |
|---|
| Anmerkungen: |
Date Completed 29.07.2019 Date Revised 29.07.2019 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.hfc.2019.02.009 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM296988081 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM296988081 | ||
| 003 | DE-627 | ||
| 005 | 20231225091024.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.hfc.2019.02.009 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0989.xml |
| 035 | |a (DE-627)NLM296988081 | ||
| 035 | |a (NLM)31079699 | ||
| 035 | |a (PII)S1551-7136(19)30020-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bencivenga, Leonardo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a β-Adrenergic Receptor Signaling and Heart Failure |b From Bench to Bedside |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.07.2019 | ||
| 500 | |a Date Revised 29.07.2019 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2019 Elsevier Inc. All rights reserved. | ||
| 520 | |a Despite improvements in management and therapeutic approach in the last decades, heart failure is still associated with high mortality rates. The sustained enhancement in the sympathetic nervous system tone, observed in patients with heart failure, causes alteration in β-adrenergic receptor signaling and function. This latter phenomenon is the result of several heart failure-related molecular abnormalities involving adrenergic receptors, G-protein-coupled receptor kinases, and β-arrestins. This article summarizes novel encouraging preclinical strategies to reactivate β-adrenergic receptor signaling in heart failure, including pharmacologic and gene therapy approaches, and attempts to translate acquired notions into the clinical setting | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a G-protein-coupled receptors | |
| 650 | 4 | |a GRK | |
| 650 | 4 | |a Heart failure | |
| 650 | 4 | |a Therapies | |
| 650 | 4 | |a β-Adrenergic receptors | |
| 650 | 4 | |a β-Arrestin | |
| 650 | 7 | |a Receptors, Adrenergic, beta |2 NLM | |
| 700 | 1 | |a Liccardo, Daniela |e verfasserin |4 aut | |
| 700 | 1 | |a Napolitano, Carmen |e verfasserin |4 aut | |
| 700 | 1 | |a Visaggi, Lucia |e verfasserin |4 aut | |
| 700 | 1 | |a Rengo, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Leosco, Dario |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Heart failure clinics |d 2005 |g 15(2019), 3 vom: 01. Juli, Seite 409-419 |w (DE-627)NLM16922712X |x 1551-7136 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2019 |g number:3 |g day:01 |g month:07 |g pages:409-419 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.hfc.2019.02.009 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2019 |e 3 |b 01 |c 07 |h 409-419 | ||